Stock Detail
Videos
Fertility Frontiers: Leading Edge Technologies Addressing the Fertility Market KOL Panel
This panel explores the dynamic realm of leading-edge technologies within the fertility market. Speakers include Steve Shum, CEO at INVO Bioscience and David Wolf, CEO at Hamilton Thorne Ltd. This KOL Panel was recorded during the Lytham Partners Fall 2023 Investor...
INVO Bioscience (INVO) Company Webcast
INVO Bioscience is a healthcare services fertility company dedicated to expanding the assisted reproductive technology ("ART") marketplace by making fertility care accessible and inclusive to people around the world. Our commercialization strategy is focused on the...
INVO Bioscience (INVO) Fireside Chat
During this fireside chat we welcome INVO Bioscience, ticker symbol of INVO on the NASDAQ and their CEO, Mr. Steve Shum. INVO is a healthcare services fertility company dedicated to expanding the assisted reproductive technology ("ART") marketplace by making fertility...
News
NAYA Biosciences to Present Translational Insights to Support Phase I/IIa Clinical Trials for its GPC3-Targeting NK Engager Bispecific Antibody at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Abstracts demonstrate reversal of resistance to PD1 checkpoint blockade and predictive AI model of HCC survival rateSARASOTA, Fla. and MIAMI, Oct. 31, 2024 -- NAYA Biosciences ("NAYA") (NASDAQ: NAYA), a life science portfolio company dedicated to bringing breakthrough...
NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular Carcinoma
SARASOTA, Fla. and MIAMI, Oct. 24, 2024 -- NAYA Biosciences ("NAYA") (NASDAQ: NAYA), a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and fertility, today announced an update regarding its...
INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA Biosciences
New Trading Symbol "NAYA" Effective Tuesday October 22, 2024SARASOTA, Fla. and MIAMI, Oct. 21, 2024 -- INVO Biosciences (Nasdaq: INVO), a company focused on expanding its portfolio of clinical and commercial-stage assets in fertility, oncology, and autoimmune diseases...